Rosiglitazone meta-analysis: full impact on prescribing yet to be felt

被引:0
|
作者
机构
关键词
Public Health; Metformin; Safety Profile; Rosiglitazone; Safety Concern;
D O I
10.2165/00128415-200812000-00014
中图分类号
学科分类号
摘要
引用
收藏
页码:6 / 6
相关论文
共 50 条
  • [1] Full effects of Asian crisis yet to be felt
    Beagle, J
    Myers, T
    ADHESIVES AGE, 1998, 41 (08): : 8 - 8
  • [2] Analytical Issues Regarding Rosiglitazone Meta-analysis
    Claggett, Brian
    Wei, Lee-Jen
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (02) : 179 - 180
  • [3] Inaccuracy in meta-analysis on rosiglitazone and myocardial infarction
    Monami, M.
    Bigiarini, M.
    Rotella, Carlo M.
    Mannucci, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (02) : E7 - E8
  • [4] Meta-Analysis with Rosiglitazone: What's the Fuss?
    Friedrich, Jan O.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2008, 61 : 30 - 31
  • [5] Impact of treatment with orlistat according to European prescribing guidelines:: a meta-analysis
    Rössner, S
    Krempf, M
    OBESITY RESEARCH, 2001, 9 : 180S - 180S
  • [6] Meta-analysis shows increased myocardial infarction with rosiglitazone
    Holt, Richard I. G.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 764 - 764
  • [7] Analytical Issues Regarding Rosiglitazone Meta-analysis In reply
    Nissen, Steven E.
    Wolski, Kathy
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (02) : 180 - 180
  • [9] Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials
    Monami, Matteo
    Lamanna, Caterina
    Marchionni, Niccolo
    Mannucci, Edoardo
    DIABETES CARE, 2008, 31 (07) : 1455 - 1460
  • [10] Simpson's paradox visualized:: The example of the Rosiglitazone meta-analysis
    Ruecker, Gerta
    Schumacher, Martin
    BMC MEDICAL RESEARCH METHODOLOGY, 2008, 8 (1)